A novel iLDS statistic uncovers adaptive gene sweeps in gut bacteria, highlighting evolutionary responses to modern diets and enhancing microbiome studies.

DEAR DR. ROACH: I am a 76-year-old male who is in relatively good health. For the past six months, I have been experiencing ...

Dear Dr. Roach: Your recent column noted that a few people need to take antibiotics before dental procedures to prevent a prosthetic knee infection. My friend doesn't have a joint or heart problem, ...

Opioid Use Linked to Higher Risk of C. Diff Infection, Study Finds WEDNESDAY, Dec. 10, 2025 (HealthDay News) — Taking opioids may make some patients more likely to develop a dangerous infection, new ...

In a review of nearly 120,000 patients, 31% taking opioids developed C. diff, compared to 17% not taking them Opioids may weaken immunity and disrupt healthy gut bacteria, making infection more likely ...

Early each morning, Jesús Villalonga heads out to the woods near his home in Cuba’s Matanzas province, east of Havana, to gather medicinal plants and collect his horse from the nearby fields.

Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...

Complementary therapies for treating irritable bowel syndrome with constipation include exercise, probiotics, peppermint oil ...

Effecty requires no membership or insurance and includes unlimited messaging with your care team for ongoing support and dose ...

AstraZeneca (AZN) announced an update on their ongoing clinical study. Study Overview AstraZeneca is running a Phase IIb study titled “A Phase IIb, Randomized, Double-blind, Placebo-controlled Study ...

Intense pain during a bowel movement sent our son to the ER. He got diagnosed with a blood clot in a hemorrhoid and needed surgery to fix it.

Corona Remedies Ltd made a spectacular stock market debut on Monday with shares of the drugmaker that counts private equity firm ChrysCapital as an investor listing at a premium of nearly 37% to its ...